These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 19864667)

  • 21. Treatment-responsive pudendal dysfunction in chronic inflammatory demyelinating polyneuropathy.
    Bussemaker L; Schelhaas HJ; Overeem S; Hopman WP; Zwarts MJ
    Neurology; 2007 Mar; 68(12):957-8. PubMed ID: 17372137
    [No Abstract]   [Full Text] [Related]  

  • 22. Contactin 1 IgG4 associates to chronic inflammatory demyelinating polyneuropathy with sensory ataxia.
    Miura Y; Devaux JJ; Fukami Y; Manso C; Belghazi M; Wong AH; Yuki N;
    Brain; 2015 Jun; 138(Pt 6):1484-91. PubMed ID: 25808373
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chronic inflammatory demyelinating polyradiculoneuropathy in diabetic patients.
    Haq RU; Pendlebury WW; Fries TJ; Tandan R
    Muscle Nerve; 2003 Apr; 27(4):465-70. PubMed ID: 12661048
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Auditory dysfunction in chronic inflammatory demyelinating polyradiculoneuropathy.
    Hengstman GJ; Schelhaas HJ; Zwarts MJ
    Neurology; 2004 Apr; 62(8):1446-8. PubMed ID: 15111702
    [No Abstract]   [Full Text] [Related]  

  • 25. Chronic inflammatory demyelinating polyneuropathy in patients with systemic lupus erythematosus: prognosis and outcome.
    Vina ER; Fang AJ; Wallace DJ; Weisman MH
    Semin Arthritis Rheum; 2005 Dec; 35(3):175-84. PubMed ID: 16325658
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chronic inflammatory demyelinating polyradiculoneuropathy: in a remote northern Ontario hospital.
    Taylor T
    Can Fam Physician; 2013 Apr; 59(4):368-71. PubMed ID: 23585604
    [No Abstract]   [Full Text] [Related]  

  • 27. Predicting treatment responses to IV immunoglobulins: can we already ask the genes?
    Lehmann HC; Kieseier BC
    Neurology; 2009 Oct; 73(17):1344-5. PubMed ID: 19776375
    [No Abstract]   [Full Text] [Related]  

  • 28. Chronic inflammatory demyelinating polyradiculoneuropathy with ataxia.
    Stockdale RC; Biswas CK
    J R Soc Med; 2004 Jul; 97(7):338-9. PubMed ID: 15229265
    [No Abstract]   [Full Text] [Related]  

  • 29. [Chronic inflammatory demyelinating polyradiculoneuropathy].
    Franques J; Azulay JP; Pouget J; Attarian S
    Rev Med Interne; 2010 Jun; 31(6):411-6. PubMed ID: 20395023
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chronic inflammatory demyelinating polyneuropathy associated with intestinal tuberculosis.
    Chong VH; Joseph TP; Telisinghe PU; Jalihal A
    J Microbiol Immunol Infect; 2007 Aug; 40(4):377-80. PubMed ID: 17712474
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impairment of renal function after intravenous immunoglobulin.
    Soares SM; Sethi S
    Nephrol Dial Transplant; 2006 Mar; 21(3):816-7. PubMed ID: 16399766
    [No Abstract]   [Full Text] [Related]  

  • 32. Successful treatment of chronic inflammatory demyelinating polyneuropathy (CIDP) in systemic lupus erythematosus (SLE) with oral cyclophosphamide.
    Jasmin R; Sockalingam S; Shahrizaila N; Cheah TE; Zain AA; Goh KJ
    Lupus; 2012 Sep; 21(10):1119-23. PubMed ID: 22433918
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Plasmacytosis is a common immune signature in patients with MMN and CIDP and responds to treatment with IVIg.
    Korporal-Kuhnke M; Haas J; Schwarz A; Jarius S; Wildemann B
    J Neuroimmunol; 2015 Jan; 278():60-8. PubMed ID: 25595253
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term outcome in chronic inflammatory demyelinating polyneuropathy patients treated with intravenous immunoglobulin: a retrospective study.
    Querol L; Rojas-Garcia R; Casasnovas C; Sedano MJ; Muñoz-Blanco JL; Alberti MA; Paradas C; Sevilla T; Pardo J; Capablo JL; Sivera R; Guerrero A; Gutierrez-Rivas E; Illa I
    Muscle Nerve; 2013 Dec; 48(6):870-6. PubMed ID: 23512566
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hyperpyrexia-triggered relapses in an unusual case of ataxic chronic inflammatory demyelinating polyradiculoneuropathy.
    Mazzucco S; Ferrari S; Mezzina C; Tomelleri G; Bertolasi L; Rizzuto N
    Neurol Sci; 2006 Jul; 27(3):176-9. PubMed ID: 16897630
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Spreading of autoimmunity from central to peripheral myelin: two cases of clinical association between multiple sclerosis and chronic inflammatory demyelinating polyneuropathy.
    Falcone M; Scalise A; Minisci C; Romito D; Cancelli I; Gigli GL
    Neurol Sci; 2006 Apr; 27(1):58-62. PubMed ID: 16688601
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tongue fasciculations in chronic inflammatory demyelinating polyradiculoneuropathy.
    Hemmi S; Kutoku Y; Inoue K; Murakami T; Sunada Y
    Muscle Nerve; 2008 Oct; 38(4):1341-3. PubMed ID: 18785185
    [No Abstract]   [Full Text] [Related]  

  • 38. Subcutaneous immunoglobulin infusion: a new therapeutic option in chronic inflammatory demyelinating polyneuropathy.
    Lee DH; Linker RA; Paulus W; Schneider-Gold C; Chan A; Gold R
    Muscle Nerve; 2008 Mar; 37(3):406-9. PubMed ID: 17918749
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Subcutaneous immunoglobulin in responders to intravenous therapy with chronic inflammatory demyelinating polyradiculoneuropathy.
    Markvardsen LH; Debost JC; Harbo T; Sindrup SH; Andersen H; Christiansen I; Otto M; Olsen NK; Lassen LL; Jakobsen J;
    Eur J Neurol; 2013 May; 20(5):836-42. PubMed ID: 23294032
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chronic inflammatory demyelinating polyneuropathy in a patient with hyperIgEaemia.
    Kimura A; Yoshino H; Yuasa T
    J Neurol Sci; 2005 Apr; 231(1-2):89-93. PubMed ID: 15792827
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.